Emanuela Macagno

Co-founder of Isomorphic Labs at isomorphic-labs

AI researcher and entrepreneur who co-founded Isomorphic Labs as a DeepMind spinoff focused on applying AI to drug discovery and development. The company secured multi-billion dollar deals with pharmaceutical giants Eli Lilly and Novartis in 2025, demonstrating AI's transformative potential in healthcare. Macagno leads cutting-edge research translating protein folding and molecular biology breakthroughs into practical therapeutic innovations.